Ana Lleo
0000-0002-0561-7902
Humanitas University
10 papers found
Refreshing results…
Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy
Stereotactic Radiotherapy after Incomplete Transarterial (Chemo-) Embolization (TAE\TACE) versus Exclusive TAE or TACE for Treatment of Inoperable HCC: A Phase III Trial (NCT02323360)
Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target
Cholangiocarcinoma landscape in Europe: Diagnostic, prognostic and therapeutic insights from the ENSCCA Registry
Hepatotoxicity in Patients with Hepatocellular Carcinoma on Treatment with Immune Checkpoint Inhibitors
Clinical Outcomes in the Second versus First Pandemic Wave in Italy: Impact of Hospital Changes and Reorganization
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
Macrophage morphology correlates with single-cell diversity and prognosis in colorectal liver metastasis
COVID‐19 and liver cancer clinical trials: not everything is lost
The tumour microenvironment and immune milieu of cholangiocarcinoma
Missing publications? Search for publications with a matching author name.